Description
| Contents | Vial: IGF1(Insulin-Like Growth Factor1) Long R3 125mcg. Ampule: 2ml Sterile water for injection. |
| Administration | Intramuscular injection. |
| Storage | Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution. |
| Dosage | Initial: .5 mcg/kg/day. May increase dose gradually. Max: 5 mcg/kg/day. Maximum period for administration 45 days. |
| Contraindications | Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or pre-proliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have a severe respiratory impairment. |
| Special Precautions | Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumor growth. Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis. |
| Adverse Drug Reactions | Side effects noted are tiredness, feeling of lethargy, head rush or euphoria, itching. |
| Drug Interactions | High doses of corticosteroid may inhibit growth-promoting effects of IGF1LR3. |
| Disclaimer | “Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice.” |
Reviews
There are no reviews yet.